T-E Meds, an Immunwork’s affiliated company, has been selected as a finalist for the Start-up Stadium pitching competition in the BIO International Convention. T-E Meds stands out through its innovative “Multi-Arm Linker” technology platform. This technology can be utalized to design and create novel ADC/ARC drugs to improve the efficacy and safety. T-E Meds was … Continue reading BIO 2023 International Convention in Boston